Company Spotlight / Acıbadem's Grand Ambitions
There is perhaps no Turkish company in the healthcare sector that is more ambitious than Acıbadem. Not only has…
Top Stories
Cell & Gene Therapy / US FDA's Efforts to Advance the Development of Gene Therapy
Peter Marks, director of the US FDA's Center for Biologics Evaluation and Research, outlines how the organization is attempting to further promote the advancement of cutting edge cell and gene…
Top 10 / Chinese Pharma Companies
China’s booming pharmaceutical industry has been rapidly expanding to become the second largest…
Geopolitics / Three Key Issues for Pharma: Protests, Pricing & India’s Modicare
This month, Aditya Bhattacharji takes stock of three political issues that are dominating Eurasia Group’s…
Company Spotlight / Zentiva's Aggressive Internationalization Strategy
Despite being recently divested from multinational pharma giant Sanofi, Czech firm Zentiva is becoming one of the…
Access / UAE: A World Leader for Early Access to Innovation
The UAE ranks as a world leader in rapid drug approvals with its fast-track registration system that accelerates…
M&A / Private Equity Targeting Healthcare & Consulting Comms Companies
Anthony Harrington of global investment banking and asset management firm Alantra outlines why healthcare and…
In Conversation
Felix Negrón – VP Puerto Rico Operations, Medtronic
Felix Negrón, VP of Puerto Rico Operations for Medtronic, the largest life sciences company on the island, explains their unique footprint in Puerto Rico and what the company has learnt in dealing with natural disasters to guarantee a continued supply of products. Moreover, he discusses his strategy to continue growing in Puerto Rico, since the territory is responsible for 18…
Pharma Faces
Diana Bracco
President & CEO | Bracco
President & CEO | Bracco
Mitsuo Sawai
President | Sawai Pharmaceutical
President | Sawai Pharmaceutical
Pierluigi Antonelli
CEO | Angelini Pharma
CEO | Angelini Pharma
Latest Reports
Focus on Thailand
3 Key Trends in Thai Medtech
Thailand country managers from three of the world’s largest medtech firms…
Company Profile: Novo Nordisk Thailand
Every generation of Novo Nordisk’s insulin portfolio is currently on the Thai…
Fostering Thai Innovation Through International Alliances
Nares Damrongchai has been the CEO of the Thailand Center of Excellence for Life…
Cultivating a Clinical Research Landscape in Thailand
As Thailand’s focus has shifted towards R&D over the past few years, the…
Read more from Thailand >>
Focus on UAE
UAE Pharma Growth Projection Snapshot
The UAE pharma market is projected to grow over 80 percent by 2027, in part due…
UAE Accelerated Drug Approvals
The UAE ranks among the world's fastest for new drug approvals, ranking first…
UAE: A World Leader for Early Access to Innovation
The UAE ranks as a world leader in rapid drug approvals with its fast-track…
Dubai Aims to Go Paperless by 2021
Dubai's government has announced its ambition to go completely paper-free by the…
Read more from UAE >>
Focus on India
Gujarat: The Home of Indian Pharma
The state of Gujarat proudly stands as India’s main pharmaceutical hub,…
CEO Profile: Vivek Sharma, PPS
Unlike many of his pharma peers, Vivek Sharma worked in operations and finance…
China: Indian Pharma Firms Incoming
The pharmaceutical industries of China and India, historically focused on their…
India Healthcare: “Modicare” Lives On
Aditya Bhattacharji is Healthcare Practice Head at Eurasia Group. In this…
Read more from India >>
Focus on Sweden
Hot Topics in Swedish Pharma
We recently analysed the contents of 20 interviews conducted with country…
The 2019 Nobel Prize in Physiology or Medicine
The 2019 Nobel Prize in Physiology or Medicine was awarded to three scientists…
Sweden’s Orexo: Helping Tackle the US Opioid Crisis
Swedish firm Orexo AB, despite its relatively small stature, is playing a major…
Sweden’s Quality Registries: A Gold Mine of Real-World…
Thanks to the cooperation of its citizens, Sweden boasts a comprehensive patient…
Read more from Sweden >>
Focus on Hungary
Four Companies to Know in Hungary
The pharmaceutical industry is one of the pillars of the Hungarian economy and…
R&D: Progress & Potential in Hungary
Investments in research and development are on the rise in Hungary, backed up by…
Hungary’s National Champions Betting on Biosimilars
Hungary’s two largest pharma firms, Egis Pharmaceuticals and Gedeon Richter,…
Drug Shortages Hitting Hungary Hard
Like many of its European counterparts, Hungary is suffering from medicine…
Read more from Hungary >>
Focus on Switzerland
Outsourced Manufacturing: A Swiss Specialty
Unknown to some, Switzerland meanwhile remains both influential and relevant in…
Switzerland: Fresh Tactics in the War on Cancer
With cancer now causing one in eight deaths globally and, in Europe, even…
Beyond Generics: Dr Reddy’s Going Global
Indian generics powerhouse Dr. Reddy’s has prioritized biosimilars as a key…
Legacy Healthcare: Countering A Silent Pandemic
Worldwide, severe side effects from classic medicine are becoming a health risk…
Read more from Switzerland >>
Focus on Puerto Rico
Did You Know? Medtech in Puerto Rico
Four top facts you may have missed about Puerto Rico's medical device…
Puerto Rico: Harnessing Technology in Pharma Manufacturing
Three heads of manufacturing for big pharma affiliates in Puerto Rico elaborate…
5 Top Pharma Manufacturers in Puerto Rico
A long list of multinational pharma companies count Puerto Rico as one of their…
Did You Know? Puerto Rican Pharma Manufacturing
Puerto Rico is home to the manufacturing plants for many of the world's top…
Read more from Puerto Rico >>
Focus on China
China’s MAH System and Bringing New Drugs to Market
China's new Amended Drug Administration Law is being enacted to strengthen and…
China Cracks Down on Counterfeit and Substandard Drugs
China’s new Amended Drug Administration Law is being enacted to strengthen and…
Top 10 Chinese Pharma Companies
China's booming pharmaceutical industry has been rapidly expanding to become the…
Chinese Pharma’s Latest Race to the Bottom on Pricing
China's roll-out of a 25-province expansion to the 4+7 pilot procurement scheme…